Antisense Therapeutics
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Company Activity
NEW ROLE: Anthony Filippis, | 02 Oct 2023 | |
NEW ROLE: Gil Price, Consultant Medical Director, Non-Executive Director since 2021 | 11 Oct 2021 | |
NEW ROLE: Alicia Mellors, Joint Company Secretary | 29 Mar 2021 | |
NEW ROLE: Charmaine Gittleson, Non-Executive Chair | 29 Mar 2021 | |
NEW ROLE: Nuket Desem, Director-Clinical & Regulatory Affairs | 24 Nov 2020 | |
NEW ROLE: George Tachas, Director Drug Discovery and Patents | 24 Nov 2020 | |
NEW ROLE: Graham Mitchell, Non-Executive Director | 03 Nov 2020 | |
NEW ROLE: Gary Pace, Non-Executive Director | 03 Nov 2020 | |
NEW ROLE: Robert Moses, Non-Executive Director, was Chair 2001-2021 | 03 Nov 2020 |